Atul Pande - Insider Trading & Ownership

Location
C/O Axovant Sciences, Inc., 1441 Broadway, 3 Rd Floor, New York, NY
Summary
The estimated net worth of Atul Pande is at least $2.45M dollars as of April 3, 2025. Atul Pande is the Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $2.45M.
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
All Insider Reports
All Insider Reports

Ownership of Atul Pande

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMVT Immunovant, Inc. Director $2.45M -$221K -8.27% Apr 1, 2025
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024

Insider Transactions Reported by Atul Pande:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.